MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 265 filers reported holding MYRIAD GENETICS INC in Q4 2018. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,154,818 | -30.8% | 446,061 | 0.0% | 0.01% | -30.0% |
Q2 2023 | $10,339,694 | -0.2% | 446,061 | 0.0% | 0.01% | -9.1% |
Q1 2023 | $10,361,997 | +60.1% | 446,061 | 0.0% | 0.01% | +57.1% |
Q4 2022 | $6,472,345 | -24.0% | 446,061 | 0.0% | 0.01% | -30.0% |
Q3 2022 | $8,511,000 | +5.0% | 446,061 | 0.0% | 0.01% | +11.1% |
Q2 2022 | $8,105,000 | -27.9% | 446,061 | 0.0% | 0.01% | -18.2% |
Q1 2022 | $11,241,000 | -8.7% | 446,061 | 0.0% | 0.01% | -8.3% |
Q4 2021 | $12,311,000 | -14.5% | 446,061 | 0.0% | 0.01% | -25.0% |
Q3 2021 | $14,403,000 | +5.6% | 446,061 | 0.0% | 0.02% | +14.3% |
Q2 2021 | $13,641,000 | +0.4% | 446,061 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $13,583,000 | +54.0% | 446,061 | 0.0% | 0.01% | +40.0% |
Q4 2020 | $8,821,000 | +51.6% | 446,061 | 0.0% | 0.01% | +42.9% |
Q3 2020 | $5,817,000 | +15.0% | 446,061 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $5,058,000 | -20.8% | 446,061 | 0.0% | 0.01% | -30.0% |
Q1 2020 | $6,383,000 | -47.4% | 446,061 | 0.0% | 0.01% | -33.3% |
Q4 2019 | $12,146,000 | -4.9% | 446,061 | 0.0% | 0.02% | -6.2% |
Q3 2019 | $12,771,000 | +3.1% | 446,061 | 0.0% | 0.02% | +6.7% |
Q2 2019 | $12,392,000 | -7.8% | 446,061 | +10.2% | 0.02% | -11.8% |
Q1 2019 | $13,437,000 | +14.2% | 404,728 | 0.0% | 0.02% | 0.0% |
Q4 2018 | $11,765,000 | -36.8% | 404,728 | 0.0% | 0.02% | -26.1% |
Q3 2018 | $18,617,000 | +23.1% | 404,728 | 0.0% | 0.02% | +15.0% |
Q2 2018 | $15,125,000 | +26.5% | 404,728 | 0.0% | 0.02% | +25.0% |
Q1 2018 | $11,960,000 | -14.0% | 404,728 | 0.0% | 0.02% | -5.9% |
Q4 2017 | $13,900,000 | -5.1% | 404,728 | 0.0% | 0.02% | -15.0% |
Q3 2017 | $14,643,000 | +40.0% | 404,728 | 0.0% | 0.02% | +42.9% |
Q2 2017 | $10,458,000 | +34.6% | 404,728 | 0.0% | 0.01% | +27.3% |
Q1 2017 | $7,771,000 | +15.2% | 404,728 | 0.0% | 0.01% | +10.0% |
Q4 2016 | $6,747,000 | +83.8% | 404,728 | +126.9% | 0.01% | +100.0% |
Q3 2016 | $3,671,000 | -32.7% | 178,375 | 0.0% | 0.01% | -37.5% |
Q2 2016 | $5,458,000 | -18.3% | 178,375 | 0.0% | 0.01% | -20.0% |
Q1 2016 | $6,677,000 | -13.3% | 178,375 | 0.0% | 0.01% | -16.7% |
Q4 2015 | $7,699,000 | +15.2% | 178,375 | 0.0% | 0.01% | +9.1% |
Q3 2015 | $6,685,000 | +10.3% | 178,375 | 0.0% | 0.01% | +22.2% |
Q2 2015 | $6,063,000 | -4.0% | 178,375 | 0.0% | 0.01% | 0.0% |
Q1 2015 | $6,314,000 | +3.9% | 178,375 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $6,075,000 | -11.7% | 178,375 | 0.0% | 0.01% | -10.0% |
Q3 2014 | $6,880,000 | -0.9% | 178,375 | 0.0% | 0.01% | 0.0% |
Q2 2014 | $6,942,000 | +33.8% | 178,375 | +17.5% | 0.01% | +25.0% |
Q1 2014 | $5,190,000 | +63.0% | 151,800 | 0.0% | 0.01% | +60.0% |
Q4 2013 | $3,185,000 | -10.7% | 151,800 | 0.0% | 0.01% | -16.7% |
Q3 2013 | $3,567,000 | – | 151,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |